Molecular Cancer BioMed Central (original) (raw)

Enhancing the anti-angiogenic action of histone deacetylase inhibitors

Murray Norris

Molecular Cancer, 2007

View PDFchevron_right

Targeting tumor angiogenesis with histone deacetylase inhibitors

Peter Atadja

Cancer Letters, 2009

View PDFchevron_right

Review Potential use of histone deacetylase inhibitors in cancer therapy

Joanna Strzelczyk

Współczesna Onkologia, 2015

View PDFchevron_right

Directing The Role of Histone Deacetylase Inhibitors in Cancer Therapy: A Review

Bhavini Gharia

2019

View PDFchevron_right

The Histone Deacetylase Inhibitor NVP-LAQ824 Inhibits Angiogenesis and Has a Greater Antitumor Effect in Combination with the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor PTK787/ZK222584

Peter Atadja

Cancer Research, 2004

View PDFchevron_right

Histone deacetylase inhibitors as a potential therapeutic agent for human cancer treatment

Evangelos Misiakos

Targeted Oncology, 2006

View PDFchevron_right

CRA-026440: a potent, broad-spectrum, hydroxamic histone deacetylase inhibitor with antiproliferative and antiangiogenic activity in vitro and in vivo

Christine Orr

Molecular cancer …, 2006

View PDFchevron_right

Histone deacetylase inhibitors as anti-neoplastic agents

Nicolas Batty

Cancer Letters, 2009

View PDFchevron_right

Histone Deacetylase Inhibitors in the Treatment of Hematological Malignancies and Solid Tumors

Giuseppe Giannini

Journal of Biomedicine and Biotechnology, 2011

View PDFchevron_right

Rational Development of Histone Deacetylase Inhibitors as Anticancer Agents: A Review

William Figg

Molecular Pharmacology, 2005

View PDFchevron_right

Histone deacetylase inhibitors—turning epigenic mechanisms of gene regulation into tools of therapeutic intervention in malignant and other diseases

Andreas Schwienhorst

Applied Microbiology and Biotechnology, 2007

View PDFchevron_right

Histone Deacetylase Inhibitors in Cancer Therapy: Latest Developments, Trends and Medicinal Chemistry Perspective

Andrew Lane

Anti-Cancer Agents in Medicinal Chemistry, 2007

View PDFchevron_right

Histone Deacetylase Inhibitors: A New Wave of Molecular Targeted Anticancer Agents

Alfredo Budillon

Recent Patents on Anti-Cancer Drug Discovery, 2007

View PDFchevron_right

Mechanisms of Selective Anticancer Action of Histone Deacetylase Inhibitors

Saverio Minucci

Cell Cycle, 2005

View PDFchevron_right

Current perspective of histone deacetylase inhibitors: A review

IP Innovative Publication Pvt. Ltd.

IP Innovative Publication Pvt. Ltd., 2018

View PDFchevron_right

Histone Deacetylase Inhibitor as a Novel Anticancer Agent: A Review

pranit saraswat

2015

View PDFchevron_right

Targeting histone deacetylase in cancer therapy

Chang-shi Chen

Medicinal Research Reviews, 2006

View PDFchevron_right

Recent Progress in Histone Deacetylase Inhibitors as Anticancer Agents

Loredana Cappellacci

Current Medicinal Chemistry, 2020

View PDFchevron_right

Multi-Targeted Histone Deacetylase Inhibitors in Cancer Therapy

Current Medicinal Chemistry

View PDFchevron_right

SB939, a Novel Potent and Orally Active Histone Deacetylase Inhibitor with High Tumor Exposure and Efficacy in Mouse Models of Colorectal Cancer

Stefan Hart

Molecular Cancer Therapeutics, 2010

View PDFchevron_right

doi:10.1155/2011/475641 Review Article Histone Deacetylase Inhibitors in the Treatment of

Luigi Bagella

2010

View PDFchevron_right

Targeting histone deacetylases for cancer therapy: from molecular mechanisms to clinical implications

Wei-guo Zhu

International journal of biological sciences, 2014

View PDFchevron_right

Histone Deacetylase Inhibitors in Cancer

ABDULRAHMAN ALSUBHI

The Egyptian Journal of Hospital Medicine, 2018

View PDFchevron_right

Molecular and Biologic Analysis of Histone Deacetylase Inhibitors with Diverse Specificities

Saverio Minucci

Molecular Cancer Therapeutics, 2013

View PDFchevron_right

Histone Deacetylase Inhibitors in the Treatment of Hematological Malignancies

Valentina Bizzarro

View PDFchevron_right

Targeting Histone Deacetylases: Opportunities for Cancer Treatment and Chemoprevention

Katarina Nikolic

Pharmaceutics, 2022

View PDFchevron_right

Natural Product Inhibitors of Histone Deacetylases as New Anticancer Agents

Tomris Ozben

Current protein & peptide science, 2018

View PDFchevron_right